Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Arovella Therapeutics Limited ( (AU:ALA) ) is now available.
Arovella Therapeutics Limited has announced the appointment of Andrew Nash as a director, effective from November 12, 2025. The initial director’s interest notice reveals that Andrew Nash currently holds no relevant interests in securities or contracts related to the company. This announcement is a procedural update required under listing rules, and it provides transparency to stakeholders about the director’s financial interests, ensuring compliance with corporate governance standards.
More about Arovella Therapeutics Limited
Average Trading Volume: 1,436,509
Technical Sentiment Signal: Sell
Current Market Cap: A$105.5M
Learn more about ALA stock on TipRanks’ Stock Analysis page.